antibodies
Nov 30, 2016
The next generation of ‘weaponized antibody’ therapies
Efforts to develop antibodies that can ferry drugs into cancer cells and minimize damage to healthy tissue are gathering steam. The next generation of these ‘weaponized antibody’ therapies, called antibody–drug conjugates (ADCs), is working its way through clinical trials. The concept that underlies these drugs is s...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
